You are here: Industry Insights > MHRA

News List

Blood pressure and heart medication recalled by MHRA in UK europeanpharmaceuticalreview
April 16, 2019
The MHRA have announced another sartan-containing drug product over fears that it is contaminated with the carcinogen N‑nitrosodiethylamine…
Sharp Gets MHRA Approval for Clinical Services CoE ontractpharma
April 16, 2019
Can now offer a range of clinical and commercial services from the $12 million facility.
MHRA investigates opioid regulation as addiction crisis deepens pharmaphorum
February 20, 2019
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has convened an Expert Working Group (EWG) to assess the risks and benefits of opioid medicines and see if current UK regulation is up to scratch
Chinese patients to get new drugs before UK after Brexit – says CEO pharmaphorum
February 15, 2019
US, European, Japanese and Chinese patients could get novel medicines ahead of patients in the UK after Brexit, the CEO of French pharma Ipsen has said in an interview.
MHRA recalls a further three batches of sartan-based products pharmaceutical-technology
February 14, 2019
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has announced it has recalled three more batches of irbesartan as part of its continued investigation into potential N-nitrosodiethylamine (NDEA) contamination of .....
Early access to Tecentriq combination granted through EAMS pharmatimes
January 03, 2019
UK patients with a form of advanced lung cancer will soon be able to access the immunotherapy drug Tecentriq (atezolizumab) in combination with Avastin (bevacizumab), carboplatin and paclitaxel chemotherapy through.
MHRA to consult on potential for no-deal Brexit pharmafile
November 20, 2018
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would be impacted by a no-deal Brexit.
MHRA to extend EpiPen expiry dates to tackle shortages pharmafile
October 19, 2018
The British government has extended the expiry date on epinephrine pens amid a shortage in the UK.
MHRA consults on new regulatory framework for ‘no-deal’ scenario pharmatimes
October 11, 2018
The Medicines and Healthcare products Regulatory Agency has launched a consultation seeking views on how its legislation and regulatory processes would have to be modified...
MHRA permits cell/gene therapy production at CGT Catapult site pharmatimes
September 13, 2018
The production of new cell and gene therapies at a manufacturing site in Stevenage - for use in health services around the world - has been given the green light...

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page